25 XP   0   0   10

HUTCHMED China Ltd
Buy, Hold or Sell?

Let's analyse HUTCHMED China Ltd together

PenkeI guess you are interested in HUTCHMED China Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of HUTCHMED China Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about HUTCHMED China Ltd

I send you an email if I find something interesting about HUTCHMED China Ltd.

Quick analysis of HUTCHMED China Ltd (30 sec.)










What can you expect buying and holding a share of HUTCHMED China Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
HK$0.87
Expected worth in 1 year
HK$1.41
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
HK$0.54
Return On Investment
2.1%

For what price can you sell your share?

Current Price per Share
HK$26.10
Expected price per share
HK$25.65 - HK$31.75
How sure are you?
50%

1. Valuation of HUTCHMED China Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$26.10

Intrinsic Value Per Share

HK$7.82 - HK$28.90

Total Value Per Share

HK$8.70 - HK$29.77

2. Growth of HUTCHMED China Ltd (5 min.)




Is HUTCHMED China Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$94.9m$81.3m$13.6m14.3%

How much money is HUTCHMED China Ltd making?

Current yearPrevious yearGrowGrow %
Making money$100.7m-$360.8m$461.6m458.0%
Net Profit Margin12.0%-84.6%--

How much money comes from the company's main activities?

3. Financial Health of HUTCHMED China Ltd (5 min.)




What can you expect buying and holding a share of HUTCHMED China Ltd? (5 min.)

Welcome investor! HUTCHMED China Ltd's management wants to use your money to grow the business. In return you get a share of HUTCHMED China Ltd.

What can you expect buying and holding a share of HUTCHMED China Ltd?

First you should know what it really means to hold a share of HUTCHMED China Ltd. And how you can make/lose money.

Speculation

The Price per Share of HUTCHMED China Ltd is HK$26.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of HUTCHMED China Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in HUTCHMED China Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.87. Based on the TTM, the Book Value Change Per Share is HK$0.13 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.41 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of HUTCHMED China Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.120.5%0.120.5%-0.42-1.6%-0.16-0.6%-0.11-0.4%
Usd Book Value Change Per Share0.020.1%0.020.1%-0.05-0.2%0.010.0%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.1%0.020.1%-0.05-0.2%0.010.0%0.010.1%
Usd Price Per Share3.66-3.66-3.06-2.79-1.75-
Price to Earnings Ratio31.04-31.04--7.34--1.69--1.06-
Price-to-Total Gains Ratio213.57-213.57--59.25-86.86-86.86-
Price to Book Ratio32.96-32.96-32.59-23.04-14.40-
Price-to-Total Gains Ratio213.57-213.57--59.25-86.86-86.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.33297
Number of shares300
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.020.01
Gains per Quarter (300 shares)5.152.97
Gains per Year (300 shares)20.5911.89
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1021110122
20413202414
30625303626
40827404838
501039505950
6012411607162
7014413708374
8016515809586
90185179010798
1002062000119110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.06.00.025.0%2.06.00.025.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%5.03.00.062.5%5.03.00.062.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%5.03.00.062.5%5.03.00.062.5%

Fundamentals of HUTCHMED China Ltd

About HUTCHMED China Ltd

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.

Fundamental data was last updated by Penke on 2024-04-14 11:48:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of HUTCHMED China Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit HUTCHMED China Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 12.0% means that $0.12 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of HUTCHMED China Ltd:

  • The MRQ is 12.0%. The company is making a huge profit. +2
  • The TTM is 12.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.0%TTM12.0%0.0%
TTM12.0%YOY-84.6%+96.6%
TTM12.0%5Y-46.8%+58.9%
5Y-46.8%10Y-34.3%-12.5%
1.1.2. Return on Assets

Shows how efficient HUTCHMED China Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 61.7% Return on Assets means that HUTCHMED China Ltd generated $0.62 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of HUTCHMED China Ltd:

  • The MRQ is 61.7%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 61.7%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ61.7%TTM61.7%0.0%
TTM61.7%YOY-274.5%+336.2%
TTM61.7%5Y-127.7%+189.3%
5Y-127.7%10Y-94.6%-33.1%
1.1.3. Return on Equity

Shows how efficient HUTCHMED China Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 108.0% Return on Equity means HUTCHMED China Ltd generated $1.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of HUTCHMED China Ltd:

  • The MRQ is 108.0%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 108.0%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ108.0%TTM108.0%0.0%
TTM108.0%YOY-463.0%+571.0%
TTM108.0%5Y-200.2%+308.2%
5Y-200.2%10Y-143.4%-56.8%

1.2. Operating Efficiency of HUTCHMED China Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient HUTCHMED China Ltd is operating .

  • Measures how much profit HUTCHMED China Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of HUTCHMED China Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-95.6%+95.6%
TTM-5Y-69.1%+69.1%
5Y-69.1%10Y-51.4%-17.7%
1.2.2. Operating Ratio

Measures how efficient HUTCHMED China Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.44 means that the operating costs are $1.44 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 1.437. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.437. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.437TTM1.4370.000
TTM1.437YOY2.686-1.249
TTM1.4375Y2.390-0.953
5Y2.39010Y2.091+0.299

1.3. Liquidity of HUTCHMED China Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if HUTCHMED China Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.72 means the company has $2.72 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 2.722. The company is able to pay all its short-term debts. +1
  • The TTM is 2.722. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.722TTM2.7220.000
TTM2.722YOY2.373+0.348
TTM2.7225Y3.028-0.306
5Y3.02810Y3.170-0.143
1.3.2. Quick Ratio

Measures if HUTCHMED China Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.78 means the company can pay off $1.78 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 1.781. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.781. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.781TTM1.7810.000
TTM1.781YOY1.165+0.616
TTM1.7815Y3.257-1.476
5Y3.25710Y3.924-0.667

1.4. Solvency of HUTCHMED China Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of HUTCHMED China Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare HUTCHMED China Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.42 means that HUTCHMED China Ltd assets are financed with 41.9% credit (debt) and the remaining percentage (100% - 41.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 0.419. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.419. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.419TTM0.4190.000
TTM0.419YOY0.381+0.038
TTM0.4195Y0.338+0.081
5Y0.33810Y0.321+0.017
1.4.2. Debt to Equity Ratio

Measures if HUTCHMED China Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 73.4% means that company has $0.73 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 0.734. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.734. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.734TTM0.7340.000
TTM0.734YOY0.643+0.091
TTM0.7345Y0.544+0.190
5Y0.54410Y0.516+0.028

2. Market Valuation of HUTCHMED China Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings HUTCHMED China Ltd generates.

  • Above 15 is considered overpriced but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 31.04 means the investor is paying $31.04 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of HUTCHMED China Ltd:

  • The EOD is 28.230. Based on the earnings, the company is overpriced. -1
  • The MRQ is 31.042. Based on the earnings, the company is overpriced. -1
  • The TTM is 31.042. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD28.230MRQ31.042-2.812
MRQ31.042TTM31.0420.000
TTM31.042YOY-7.345+38.387
TTM31.0425Y-1.692+32.734
5Y-1.69210Y-1.058-0.635
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of HUTCHMED China Ltd:

  • The EOD is 15.243. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 16.761. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 16.761. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD15.243MRQ16.761-1.518
MRQ16.761TTM16.7610.000
TTM16.761YOY-8.682+25.443
TTM16.7615Y-4.049+20.811
5Y-4.04910Y-2.531-1.518
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of HUTCHMED China Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of HUTCHMED China Ltd:

  • The EOD is 29.971. Based on the equity, the company is expensive. -2
  • The MRQ is 32.957. Based on the equity, the company is expensive. -2
  • The TTM is 32.957. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD29.971MRQ32.957-2.986
MRQ32.957TTM32.9570.000
TTM32.957YOY32.588+0.368
TTM32.9575Y23.043+9.914
5Y23.04310Y14.402+8.641
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of HUTCHMED China Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1340.1340%-0.405+401%0.078+73%0.109+23%
Book Value Per Share--0.8710.8710%0.736+18%0.745+17%0.624+40%
Current Ratio--2.7222.7220%2.373+15%3.028-10%3.170-14%
Debt To Asset Ratio--0.4190.4190%0.381+10%0.338+24%0.321+31%
Debt To Equity Ratio--0.7340.7340%0.643+14%0.544+35%0.516+42%
Dividend Per Share----0%-0%-0%-0%
Eps--0.9250.9250%-3.268+453%-1.246+235%-0.882+195%
Free Cash Flow Per Share--1.7121.7120%-2.764+261%-0.925+154%-0.730+143%
Free Cash Flow To Equity Per Share--1.7121.7120%-3.514+305%0.644+166%0.738+132%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--28.899--------
Intrinsic Value_10Y_min--7.825--------
Intrinsic Value_1Y_max---0.101--------
Intrinsic Value_1Y_min---0.569--------
Intrinsic Value_3Y_max--1.980--------
Intrinsic Value_3Y_min---0.549--------
Intrinsic Value_5Y_max--6.815--------
Intrinsic Value_5Y_min--0.746--------
Market Cap22280109235.200-10%24499583718.40024499583718.4000%20754608160.000+18%18854618214.680+30%11784136384.175+108%
Net Profit Margin--0.1200.1200%-0.846+804%-0.468+489%-0.343+386%
Operating Margin----0%-0.9560%-0.6910%-0.5140%
Operating Ratio--1.4371.4370%2.686-47%2.390-40%2.091-31%
Pb Ratio29.971-10%32.95732.9570%32.588+1%23.043+43%14.402+129%
Pe Ratio28.230-10%31.04231.0420%-7.345+124%-1.692+105%-1.058+103%
Price Per Share26.100-10%28.70028.7000%24.000+20%21.880+31%13.675+110%
Price To Free Cash Flow Ratio15.243-10%16.76116.7610%-8.682+152%-4.049+124%-2.531+115%
Price To Total Gains Ratio194.222-10%213.570213.5700%-59.248+128%86.860+146%86.860+146%
Quick Ratio--1.7811.7810%1.165+53%3.257-45%3.924-55%
Return On Assets--0.6170.6170%-2.745+545%-1.277+307%-0.946+253%
Return On Equity--1.0801.0800%-4.630+529%-2.002+285%-1.434+233%
Total Gains Per Share--0.1340.1340%-0.405+401%0.078+73%0.109+23%
Usd Book Value--94930519.90094930519.9000%81328299.000+17%81702511.080+16%68327369.513+39%
Usd Book Value Change Per Share--0.0170.0170%-0.052+401%0.010+73%0.014+23%
Usd Book Value Per Share--0.1110.1110%0.094+18%0.095+17%0.080+40%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.1180.1180%-0.417+453%-0.159+235%-0.113+195%
Usd Free Cash Flow--186654257.219186654257.2190%-305276504.835+264%-102148318.842+155%-70489618.323+138%
Usd Free Cash Flow Per Share--0.2190.2190%-0.353+261%-0.118+154%-0.093+143%
Usd Free Cash Flow To Equity Per Share--0.2190.2190%-0.449+305%0.082+166%0.094+132%
Usd Market Cap2845169949.335-10%3128596840.8403128596840.8400%2650363462.032+18%2407734746.015+30%1504834216.259+108%
Usd Price Per Share3.333-10%3.6653.6650%3.065+20%2.794+31%1.746+110%
Usd Profit--100784458.507100784458.5070%-360850963.340+458%-137297473.772+236%-97041917.945+196%
Usd Revenue--838036073.076838036073.0760%426427864.334+97%410698568.501+104%340614318.111+146%
Usd Total Gains Per Share--0.0170.0170%-0.052+401%0.010+73%0.014+23%
 EOD+4 -4MRQTTM+0 -0YOY+26 -65Y+24 -810Y+24 -8

3.2. Fundamental Score

Let's check the fundamental score of HUTCHMED China Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1528.230
Price to Book Ratio (EOD)Between0-129.971
Net Profit Margin (MRQ)Greater than00.120
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.781
Current Ratio (MRQ)Greater than12.722
Debt to Asset Ratio (MRQ)Less than10.419
Debt to Equity Ratio (MRQ)Less than10.734
Return on Equity (MRQ)Greater than0.151.080
Return on Assets (MRQ)Greater than0.050.617
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of HUTCHMED China Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.490
Ma 20Greater thanMa 5027.258
Ma 50Greater thanMa 10025.032
Ma 100Greater thanMa 20025.805
OpenGreater thanClose26.250
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income before Tax  -1,105,021-380,823-1,485,845271,046-1,214,799-1,999,298-3,214,0973,670,718456,622
Net Income  -830,295-154,322-984,617-539,711-1,524,327-1,301,444-2,825,7713,614,999789,228
Operating Income  -1,135,673-404,474-1,540,146-80,967-1,621,113-1,571,612-3,192,7253,336,624143,898
Net Income from Continuing Operations  -811,931-92,706-904,637-403,495-1,308,131-1,514,123-2,822,2553,613,942791,687



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets1,279,773
Total Liabilities536,386
Total Stockholder Equity730,541
 As reported
Total Liabilities 536,386
Total Stockholder Equity+ 730,541
Total Assets = 1,279,773

Assets

Total Assets1,279,773
Total Current Assets1,096,839
Long-term Assets182,934
Total Current Assets
Cash And Cash Equivalents 283,589
Short-term Investments 602,747
Net Receivables 114,998
Inventory 50,258
Total Current Assets  (as reported)1,096,839
Total Current Assets  (calculated)1,051,592
+/- 45,247
Long-term Assets
Property Plant Equipment 104,392
Long-term Assets Other 14,675
Long-term Assets  (as reported)182,934
Long-term Assets  (calculated)119,067
+/- 63,867

Liabilities & Shareholders' Equity

Total Current Liabilities403,027
Long-term Liabilities133,359
Total Stockholder Equity730,541
Total Current Liabilities
Short Long Term Debt 31,155
Accounts payable 36,327
Total Current Liabilities  (as reported)403,027
Total Current Liabilities  (calculated)67,482
+/- 335,545
Long-term Liabilities
Long term Debt 48,189
Capital Lease Obligations Min Short Term Debt6,787
Long-term Liabilities Other 11,346
Long-term Liabilities  (as reported)133,359
Long-term Liabilities  (calculated)66,322
+/- 67,037
Total Stockholder Equity
Total Stockholder Equity (as reported)730,541
Total Stockholder Equity (calculated)0
+/- 730,541
Other
Capital Stock87,126
Common Stock Shares Outstanding 853,644
Net Invested Capital 809,885
Net Working Capital 693,812
Property Plant and Equipment Gross 150,961



Balance Sheet

Currency in HKD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
342,437
597,932
532,118
465,122
724,118
1,372,661
1,029,445
1,279,773
1,279,7731,029,4451,372,661724,118465,122532,118597,932342,437
   > Total Current Assets 
167,380
432,195
370,541
317,022
530,740
1,212,076
839,888
1,096,839
1,096,839839,8881,212,076530,740317,022370,541432,195167,380
       Cash And Cash Equivalents 
48,213
85,265
86,036
121,157
235,630
272,922
313,278
283,589
283,589313,278272,922235,630121,15786,03685,26548,213
       Short-term Investments 
24,890
273,031
214,915
96,011
199,546
635,413
317,718
602,747
602,747317,718635,413199,54696,011214,915273,03124,890
       Net Receivables 
45,035
62,110
51,225
77,347
47,870
83,580
94,471
114,998
114,99894,47183,58047,87077,34751,22562,11045,035
       Inventory 
12,822
11,789
12,309
16,208
19,766
35,755
56,690
50,258
50,25856,69035,75519,76616,20812,30911,78912,822
       Other Current Assets 
372
2,015
0
0
930
0
0
0
000930002,015372
   > Long-term Assets 
0
165,737
161,577
148,100
193,378
160,585
189,557
182,934
182,934189,557160,585193,378148,100161,577165,7370
       Property Plant Equipment 
11,174
14,220
16,616
27,481
45,307
66,323
84,669
104,392
104,39284,66966,32345,30727,48116,61614,22011,174
       Goodwill 
3,137
3,308
3,186
3,112
3,307
3,380
0
0
003,3803,3073,1123,1863,3083,137
       Long Term Investments 
0
144,237
0
0
0
0
0
0
000000144,2370
       Intangible Assets 
469
430
347
275
227
163
0
0
00163227275347430469
       Long-term Assets Other 
0
0
0
0
0
21,551
15,745
14,675
14,67515,74521,55100000
> Total Liabilities 
158,167
112,966
119,863
152,219
205,169
385,768
392,575
536,386
536,386392,575385,768205,169152,219119,863112,966158,167
   > Total Current Liabilities 
95,119
104,600
85,479
113,101
158,397
311,658
353,903
403,027
403,027353,903311,658158,397113,10185,479104,60095,119
       Short-term Debt 
0
1,550
0
0
0
0
0
0
0000001,5500
       Short Long Term Debt 
0
29,987
0
0
0
26,905
0
31,155
31,155026,90500029,9870
       Accounts payable 
0
24,365
25,625
23,961
31,612
41,177
71,115
36,327
36,32771,11541,17731,61223,96125,62524,3650
       Other Current Liabilities 
0
8,919
10,968
12,021
13,255
56,491
54,449
0
054,44956,49113,25512,02110,9688,9190
   > Long-term Liabilities 
0
8,366
34,384
39,118
46,772
21,489
38,672
133,359
133,35938,67221,48946,77239,11834,3848,3660
       Long term Debt Total 
26,830
0
26,739
29,867
32,925
7,161
0
0
007,16132,92529,86726,739026,830
       Other Liabilities 
0
7,787
7,066
8,672
13,268
14,328
15,372
0
015,37214,32813,2688,6727,0667,7870
       Deferred Long Term Liability 
0
0
0
180
1,171
0
0
0
0001,171180000
> Total Stockholder Equity
184,270
461,733
388,996
288,012
484,116
986,893
610,367
730,541
730,541610,367986,893484,116288,012388,996461,733184,270
   Common Stock
60,706
66,447
66,658
66,691
72,772
86,453
86,478
0
086,47886,45372,77266,69166,65866,44760,706
   Retained Earnings -870,869-971,481-610,328-415,591-289,734-183,004-107,104-80,357
   Capital Surplus 
208,196
496,960
505,585
514,904
822,458
1,505,196
0
0
001,505,196822,458514,904505,585496,960208,196
   Treasury Stock00000000
   Other Stockholders Equity 
-4,275
5,430
-243
-3,849
4,477
5,572
-1,903
0
0-1,9035,5724,477-3,849-2435,430-4,275



Balance Sheet

Currency in HKD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue837,999
Cost of Revenue-384,447
Gross Profit453,552453,552
 
Operating Income (+$)
Gross Profit453,552
Operating Expense-819,624
Operating Income18,375-366,072
 
Operating Expense (+$)
Research Development302,001
Selling General Administrative133,176
Selling And Marketing Expenses-
Operating Expense819,624435,177
 
Net Interest Income (+$)
Interest Income36,145
Interest Expense-759
Other Finance Cost-0
Net Interest Income35,386
 
Pretax Income (+$)
Operating Income18,375
Net Interest Income35,386
Other Non-Operating Income Expenses-
Income Before Tax (EBT)58,30818,375
EBIT - interestExpense = -759
100,780
101,539
Interest Expense759
Earnings Before Interest and Taxes (EBIT)-59,067
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax58,308
Tax Provision-4,509
Net Income From Continuing Ops101,09453,799
Net Income100,780
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--35,386
 

Technical Analysis of HUTCHMED China Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of HUTCHMED China Ltd. The general trend of HUTCHMED China Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine HUTCHMED China Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of HUTCHMED China Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 31.35 < 31.50 < 31.75.

The bearish price targets are: 25.95 > 25.80 > 25.65.

Tweet this
HUTCHMED China Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of HUTCHMED China Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

HUTCHMED China Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of HUTCHMED China Ltd. The current macd is 0.49753453.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the HUTCHMED China Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for HUTCHMED China Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the HUTCHMED China Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
HUTCHMED China Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHUTCHMED China Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of HUTCHMED China Ltd. The current adx is 31.85.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy HUTCHMED China Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
HUTCHMED China Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of HUTCHMED China Ltd. The current sar is 29.44.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
HUTCHMED China Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of HUTCHMED China Ltd. The current rsi is 46.49. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
HUTCHMED China Ltd Daily Relative Strength Index (RSI) ChartHUTCHMED China Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of HUTCHMED China Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the HUTCHMED China Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
HUTCHMED China Ltd Daily Stochastic Oscillator ChartHUTCHMED China Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of HUTCHMED China Ltd. The current cci is -104.40835267.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
HUTCHMED China Ltd Daily Commodity Channel Index (CCI) ChartHUTCHMED China Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of HUTCHMED China Ltd. The current cmo is -19.83139289.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
HUTCHMED China Ltd Daily Chande Momentum Oscillator (CMO) ChartHUTCHMED China Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of HUTCHMED China Ltd. The current willr is -88.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
HUTCHMED China Ltd Daily Williams %R ChartHUTCHMED China Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of HUTCHMED China Ltd.

HUTCHMED China Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of HUTCHMED China Ltd. The current atr is 1.39384967.

HUTCHMED China Ltd Daily Average True Range (ATR) ChartHUTCHMED China Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of HUTCHMED China Ltd. The current obv is 94,846,274.

HUTCHMED China Ltd Daily On-Balance Volume (OBV) ChartHUTCHMED China Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of HUTCHMED China Ltd. The current mfi is 64.71.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
HUTCHMED China Ltd Daily Money Flow Index (MFI) ChartHUTCHMED China Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for HUTCHMED China Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

HUTCHMED China Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of HUTCHMED China Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.490
Ma 20Greater thanMa 5027.258
Ma 50Greater thanMa 10025.032
Ma 100Greater thanMa 20025.805
OpenGreater thanClose26.250
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of HUTCHMED China Ltd with someone you think should read this too:
  • Are you bullish or bearish on HUTCHMED China Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about HUTCHMED China Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about HUTCHMED China Ltd

I send you an email if I find something interesting about HUTCHMED China Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about HUTCHMED China Ltd.

Receive notifications about HUTCHMED China Ltd in your mailbox!